(Q53657387)
Statements
Phase I and pharmacokinetic study of anhydrovinblastine every 3 weeks in patients with refractory solid tumors. (English)
Nithya Ramnath
Gary N Schwartz
Patrick Smith
Daniel Bong
Peter Kanter
Joanne Berdzik
Patrick J Creaven
25 February 2003
51
3
227-230